Pharma · Private company
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Track this companyFree. Adds Johnson & Johnson Pharmaceutical Research & Development, L.L.C. to your Dealase workspace and tells you when its record changes.
Clinical trials83 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- JNJ-42160443Phase 2 · Cystitis, InterstitialClinicalTrials.gov · fetched Nov 12, 2026
- JNJ-42160443Phase 2 · OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
- Oxycodone CR (standard pain medication)Phase 2 · OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory MyelomaPHASE2 · RECRUITING · started Jul 17, 2026ClinicalTrials.gov NCT07657312 · fetched Nov 12, 2026
- Fibulink Syndesmosis Repair System With Early Full-Weight BearingNA · RECRUITING · started Jul 13, 2023ClinicalTrials.gov NCT06085586 · fetched Nov 12, 2026
- Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of BreathNA · COMPLETED · started Mar 5, 2021ClinicalTrials.gov NCT04693793 · fetched Nov 12, 2026
- The Lung PCA: A Multi-Dimensional Atlas of Pulmonary PremalignancyNA · ACTIVE_NOT_RECRUITING · started Dec 6, 2019ClinicalTrials.gov NCT03881098 · fetched Nov 12, 2026
- A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From OsteoarthritisPHASE2 · TERMINATED · started Apr 20, 2010ClinicalTrials.gov NCT01094262 · fetched Nov 12, 2026
- A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder PainPHASE2 · TERMINATED · started Apr 6, 2010ClinicalTrials.gov NCT01060254 · fetched Nov 12, 2026
- A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related PainPHASE2 · TERMINATED · started Sep 16, 2009ClinicalTrials.gov NCT00973141 · fetched Nov 12, 2026
- A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and MorphinePHASE3 · TERMINATED · started Jun 1, 2007ClinicalTrials.gov NCT00505414 · fetched Nov 12, 2026